Sharp Therapeutics Corp.
SHRX.V
TSX
| 09/30/2025 | 06/30/2025 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -36.73% | 56.18% | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | -10.21% | -34.94% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | -36.02% | 50.56% | -- | ||
|
|
|||||
| Total Current Assets | -36.02% | 50.56% | -- | ||
| Net Property, Plant & Equipment | -2.61% | -2.31% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 0.00% | 0.00% | -- | ||
| Total Assets | -28.21% | 33.69% | -- | ||
|
|
|||||
| Total Accounts Payable | -39.59% | -5.56% | -- | ||
| Total Accrued Expenses | -3.49% | 15.67% | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 124.95% | 14.52% | -- | ||
| Total Finance Division Other Current Liabilities | -- | -100.00% | -- | ||
| Total Other Current Liabilities | -- | -100.00% | -- | ||
| Total Current Liabilities | -15.85% | -79.94% | -- | ||
|
|
|||||
| Total Current Liabilities | -15.85% | -79.94% | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -5.47% | -1.12% | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | -8.49% | -53.82% | -- | ||
|
|
|||||
| Common Stock & APIC | 0.03% | 11.18% | -- | ||
| Retained Earnings | -4.68% | 2.42% | -- | ||
| Treasury Stock & Other | 30.38% | 230.65% | -- | ||
| Total Common Equity | -42.37% | 470.74% | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -42.37% | 470.74% | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -42.37% | 470.74% | -- | ||
|
|
|||||